Clinical importance of non-participation in a maximal graded exercise test on risk of non-fatal and fatal cardiovascular events and all-cause mortality: CARDIA study.
Clinical importance of non-participation in a maximal graded exercise test on risk of non-fatal and fatal cardiovascular events and all-cause mortality: CARDIA study.
复制标题
DOI:
10.1016/j.ypmed.2017.10.025
复制
发表时间:
2018-01
影响因子:
5.1
通讯作者:
Jacobs DR Jr
中科院分区:
文献类型:
--
作者:
Pettee Gabriel K;Whitaker KM;Duprez D;Sternfeld B;Lewis CE;Sidney S;Knell G;Jacobs DR Jr
While poor performance during a maximal graded exercise test (GXT) predicts cardiovascular events and premature mortality, the potential clinical importance of non-participation in a GXT, either for medical or non-medical reasons, is currently unknown. Data are from 4086 and 3547 Coronary Artery Risk Development in Young Adults (CARDIA) participants who attended the Year 7 (ages 25–37 years) and/or 20 exams (ages 38–50 years), respectively, which included a GXT. Cox proportional hazard models were used to examine the effect of GXT disposition (at Year 7 and 20, separately) on risk of non-fatal and fatal cardiovascular events and all-cause mortality obtained through 28 years of follow-up. A GXT was not conducted or completed according to protocol in 12.9% and 19.1% of participants attending the Year 7 and 20 exams, respectively. After adjustment, participants who missed the Year 20 GXT for medical reasons had a higher risk of cardiovascular events [HR: 4.06 (95% CI: 1.43, 11.5)] and all-cause mortality [HR: 3.07 (95% CI: 1.11, 12.3)] compared to GXT completers; participants who missed at Year 20 for non-medical reasons also had higher risk of all-cause mortality [HR: 2.53 (95% CI: 1.61, 3.99)]. Findings suggest that non-participation in a GXT, regardless of medical or non-medical reason, to be an important predictor of excess risk of adverse health outcomes and premature mortality. Additional patient follow-up, including identification of potential targets for intervention (e.g., weight management and smoking cessation programs), should be conducted at the point of a missed GXT.
登录
查看更多内容
DOI:
10.1016/0197-2456(91)90002-4
发表时间:
1991-02-01
期刊:
Controlled clinical trials
影响因子:
--
作者:
Cutter, G R;Burke, G L;Manolio, T A
通讯作者:
Manolio, T A
DOI:
10.1097/00008483-198911000-00003
发表时间:
1989-11-01
期刊:
Journal of cardiopulmonary rehabilitation
影响因子:
--
作者:
Jacobs, David R Jr;Hahn, Lorraine P;Sidney, Stephen
通讯作者:
Sidney, Stephen
DOI:
10.1161/01.atv.10.3.430
发表时间:
1990-05-01
期刊:
ARTERIOSCLEROSIS
影响因子:
--
作者:
MANOLIO, TA;SAVAGE, PJ;OBERMAN, A
通讯作者:
OBERMAN, A
影响因子:
37.8
作者:
Luepker, RV;Apple, FS;Tunstall-Pedoe, H
通讯作者:
Tunstall-Pedoe, H
影响因子:
24
作者:
Laukkanen, Jari A.;Makikallio, Timo H.;Kurl, Sudhir
通讯作者:
Kurl, Sudhir